Document Detail


Isolated laryngeal myokymia: diagnosis and treatment.
MedLine Citation:
PMID:  20683936     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Myokymia is an uncommon neuromuscular disorder that rarely affects the human larynx. No previous reports of isolated laryngeal myokymia are present in the literature, and as such, established treatment protocols are lacking. We report the first case of isolated laryngeal myokymia in a 48-year-old woman with no other neurological findings, and our successful results in initial treatment and maintenance therapy with focal intralaryngeal injections of botulinum toxin A.
Authors:
Jacob Sedgh; Melissa M Statham; Michael C Munin; George Small; Clark A Rosen
Related Documents :
8822386 - Somatic treatment of catatonia.
2432636 - Laser treatment of a subretinal neovascular membrane associated with retinochoroidal co...
12835426 - Forestadent young specialist prize (1999).
20686476 - Antidotes and treatments for chemical warfare/terrorism agents: an evidence-based review.
16517926 - Fatal case of community-acquired bacteremia and necrotizing fasciitis caused by chryseo...
11603256 - Fatal overdose with trazodone: case report and literature review.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The Laryngoscope     Volume:  120     ISSN:  1531-4995     ISO Abbreviation:  Laryngoscope     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-09-29     Completed Date:  2010-10-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8607378     Medline TA:  Laryngoscope     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2033-5     Citation Subset:  IM    
Affiliation:
Department of Otolaryngology, University of Pittsburgh Voice Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15219, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Botulinum Toxin Type A / therapeutic use*
Diagnosis, Differential
Female
Humans
Laryngeal Diseases / diagnosis*,  drug therapy*
Middle Aged
Myokymia / diagnosis*,  drug therapy*
Neuromuscular Agents / therapeutic use*
Chemical
Reg. No./Substance:
0/Botulinum Toxin Type A; 0/Neuromuscular Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  CX3CL1-CX3CR1 interaction prevents carbon tetrachloride-induced liver inflammation and fibrosis in m...
Next Document:  Mapping residue-specific contacts of polymyxin B with lipopolysaccharide by saturation transfer diff...